Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
45 Results
Available On-Demand
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
Alphageneron is a clinical stage Cell therapy company with both autologoius NK Cell therapy…
AltruBio is a clinical stage biopharmaceutical company with the strength in developing novel…
AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered…
Annovis Bio, Inc. (NYSE American: ANVS) is a clinical-stage, drug platform company addressing…
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq:…
Aruvant Sciences, part of the Roivant family of companies, is a clinical-stage biopharmaceutical…
aTyr’s mission is to translate novel biological pathways to develop innovative therapeutics with…
AzurRx BioPharma is a clinical stage biopharmaceutical company (NASDAQ: AZRX) focused on the…
BioInvent International AB (publ) (OMXS: BINV) is a clinical stage company that discovers and…
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the…
Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for…
Cend is a clinical-stage biotech company focused on a novel approach to enhance and more…
Cerevance, a private, clinical-stage pharmaceutical company focused on brain diseases, is applying…
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immune-modulating…
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is…
Emerald Health Pharmaceuticals (“EHP”), is a private, clinical-stage biotechnology company…
Enzychem Lifesciences (KOSDAQ:183490) is developing novel small molecule therapeutics to target…
Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory…
We are focused on the development of stem cell-derived Natural Killer cells (NK cells) as a…
Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to…
Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the…
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company…
Infinity is advancing eganelisib, a first-in-class, oral immuno-oncology development candidate that…
Ixaltis USA is bringing together a valuable set of late stage clinical assets into a dedicated…
Founded in 2015 and based in South San Francisco, Kezar (pronounced “keys are”) Life Sciences is…

Leading BioSciences is developing novel therapeutics designed to improve human health through…

Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing…
MetVital is developing a metabolic treatment that reduces free glutamate levels in the central…
Microbion is a clinical-stage pharmaceutical company developing a new class of therapeutic…
Morphogenesis is a clinical stage cell/gene therapy company focusing on a platform of cancer…
OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our…
ORYZON is a public clinical stage biopharmaceutical company and the European leader in the…
Phosplatin Therapeutics is a privately held, clinical-stage biotech company currently conducting…

Retrotope is a clinical-stage biopharmaceutical company focused on the development of first-in…

Ripple Therapeutics is a clinical stage company focused on improving ophthalmic therapeutics with…
Saniona is a biopharmaceutical company focused on discovering, developing, and delivering…
Shaperon is a clinical-stage biotech company…
Synlogic is bringing the transformational potential of synthetic biology to medicine. Synlogic’s…
Developing innovative therapeutics for Crohn's Disease, Progressive MS, HCC and COVID-19. Our…
TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the…
ViCardia is a clinical stage biopharma company entering Phase 2 with GP531, a potent, infusion…
Virios Therapeutics, Inc. (Nasdaq: VIRI) is a biotechnology company focused on advancing novel…
Vivoryon Therapeutics has an experienced discovery and development team with a strong track record…
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the…